ArticleIranian journal of child neurology2026
Combined Effects of Low-Dose Kanamycin and Noise Exposure on Auditory Brainstem Response and Cochlear Microphonic Potential in Guinea Pigs.
Article in Iranian journal of child neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Aminoglycoside‑induced ototoxicity is a well‑recognized adverse effect that commonly presents as sensorineural hearing loss. This study investigated hearing damage by administering two doses of Kanamycin, with or without concurrent noise exposure. Auditory function was assessed using auditory brainstem response and cochlear microphonic potential. Materials & Methods: Guinea pigs were divided into six groups: Control, Noise exposure, Kanamycin 300 mg/kg alone (low dose), Kanamycin 300 mg/kg + Noise, Kanamycin 500 mg/kg alone (high dose), and Kanamycin 500 mg/kg + Noise. Auditory threshold shifts were evaluated using click and pure tones at 4, 6, 8, 12, and 16 kHz. The cochlear microphonic amplitude was measured before and after intervention in the study groups. The latency and amplitude of waves I and III were analyzed in the groups without sensorineural hearing loss. Results: Auditory threshold shifts were significantly greater in the low-dose Kanamycin + noise group compared to both the low-dose Kanamycin alone and the noise-only groups across all stimuli (p < 0.05). In contrast, the high-dose Kanamycin alone and the high-dose Kanamycin + noise groups exhibited similar thresholds. They demonstrated significantly higher thresholds than the noise-only group (p < 0.05). Furthermore, no significant difference in the cochlear microphonic amplitude was found among the study groups. Conclusion: Kanamycin at low doses is not inherently ototoxic; however, when combined with noise exposure, it produces a synergistic effect resulting in severe hearing loss. In this model of auditory damage, cochlear microphonic measurements are less informative than auditory brainstem response testing, providing a more reliable assessment of both peripheral and central auditory pathway function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.